Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer-Reference-Cited by-同舟云学术

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer

Published:2001-05 Issue:8 Volume:37 Page:991-999
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ververs J.M.M.A,Roumen R.M.H,Vingerhoets A.J.J.M,Vreugdenhil G,Coebergh J.W.W,Crommelin M.A,Luiten E.J.Th,Repelaer van Driel O.J,Schijven M,Wissing J.C,Voogd A.C

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy;Larson;Int. J. Radiat. Oncol. Biol. Phys.,1986

2. Risk of lymphoedema following the treatment of breast cancer;Kissin;Br. J. Surg.,1986

3. Conservation treatment of early breast cancer;Delouche;Int. J. Radiat. Oncol. Biol. Phys.,1987

4. Arm edema in conservatively managed breast cancer;Werner;Radiology,1991

5. Hypertonie als Risikofaktor für erhöhte Nebenwirkingsraten im Rahmen der Mammacarzinombestrahlung;Böhler;Stralenther. Onkol.,1992

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supportive Exercises For Cancer Patients;New Horizons of Exercise Medicine;2024-02-01

2. Ultrasonographic Findings in Breast Cancer Patient with Shoulder Pain after Mastectomy;Clinical Pain;2023-12-31

3. The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study;Clinical Breast Cancer;2023-11

4. Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer;The Oncologist;2023-03-17

5. Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies;Clinical Breast Cancer;2022-08